Table 1.
Baseline demographic and clinical characteristics of patients who continued or terminated positive airway pressure therapy in the first year
| On Therapy (n = 86,627) | Terminating therapy (n = 11,702) | Total (n = 98,329) | |
|---|---|---|---|
| Age, years | 61 ± 12 | 63 ± 13* | 61 ± 13 |
| Gender, n (%) | |||
| Male | 66,755 (77) | 8063 (69)* | 74,818 (76) |
| Female | 19,872 (23) | 3639 (31)* | 23,511 (24) |
| Insurance, n (%) | |||
| Public | 73,949 (85) | 10,694 (91)* | 84,643 (86) |
| Private | 12,678 (15) | 1008 (9)* | 13,686 (14) |
| First PAP device, n (%) | |||
| APAP/CPAP | 78,357 (90) | 10,827 (93)* | 89,184 (91) |
| Bilevel/ASV | 8270 (10) | 875 (7)* | 9145 (9) |
Values are mean ± standard deviation, or number of patients (%)
*p < 0.05 vs patients who remained on therapy
APAP automatic continuous positive airway pressure, ASV adaptive servo-ventilation, Bilevel bilevel positive airway pressure, CPAP continuous positive airway pressure, PAP positive airway pressure